Author Topic: (ECTRIMS) Early Ocrevus use in PPMS slows disability risk, including risk of wheelchair reliance  (Read 148 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9816
  • MS diagnosed 1980
  • Location: Pacific Northwest
Re: (ECTRIMS) Genentech reports Ocrevus living up to expectations
« on: September 19, 2019, 07:44:56 pm »
A more comprehensive overview of some of the Ocrevus material presented at the ECTRIMS conference--again, from Multiple Sclerosis News Today (September 19). The spokespeople are drug company representatives.  There have been 7 PML cases so far, according to the article, but they are careful to point out these were all "carryover cases":


http://bit.ly/2kmpBr4
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
408 Views
Last post September 18, 2016, 09:56:46 am
by agate
1 Replies
166 Views
Last post December 07, 2016, 03:02:57 pm
by agate
0 Replies
135 Views
Last post January 26, 2018, 09:46:57 pm
by agate
0 Replies
42 Views
Last post September 14, 2020, 12:59:37 pm
by agate
0 Replies
17 Views
Last post July 21, 2023, 09:43:46 pm
by agate